Lindborg Beth A, Brekke John H, Vegoe Amanda L, Ulrich Connor B, Haider Kerri T, Subramaniam Sandhya, Venhuizen Scott L, Eide Cindy R, Orchard Paul J, Chen Weili, Wang Qi, Pelaez Francisco, Scott Carolyn M, Kokkoli Efrosini, Keirstead Susan A, Dutton James R, Tolar Jakub, O'Brien Timothy D
Stem Cell Institute, University of Minnesota, Minneapolis, Minnesota, USA Bioactive Regenerative Therapeutics, Inc., Two Harbors, Minnesota, USA Department of Veterinary Population Medicine, University of Minnesota, St. Paul, Minnesota, USA.
Bioactive Regenerative Therapeutics, Inc., Two Harbors, Minnesota, USA.
Stem Cells Transl Med. 2016 Jul;5(7):970-9. doi: 10.5966/sctm.2015-0305. Epub 2016 May 13.
Tissue organoids are a promising technology that may accelerate development of the societal and NIH mandate for precision medicine. Here we describe a robust and simple method for generating cerebral organoids (cOrgs) from human pluripotent stem cells by using a chemically defined hydrogel material and chemically defined culture medium. By using no additional neural induction components, cOrgs appeared on the hydrogel surface within 10-14 days, and under static culture conditions, they attained sizes up to 3 mm in greatest dimension by day 28. Histologically, the organoids showed neural rosette and neural tube-like structures and evidence of early corticogenesis. Immunostaining and quantitative reverse-transcription polymerase chain reaction demonstrated protein and gene expression representative of forebrain, midbrain, and hindbrain development. Physiologic studies showed responses to glutamate and depolarization in many cells, consistent with neural behavior. The method of cerebral organoid generation described here facilitates access to this technology, enables scalable applications, and provides a potential pathway to translational applications where defined components are desirable.
Tissue organoids are a promising technology with many potential applications, such as pharmaceutical screens and development of in vitro disease models, particularly for human polygenic conditions where animal models are insufficient. This work describes a robust and simple method for generating cerebral organoids from human induced pluripotent stem cells by using a chemically defined hydrogel material and chemically defined culture medium. This method, by virtue of its simplicity and use of defined materials, greatly facilitates access to cerebral organoid technology, enables scalable applications, and provides a potential pathway to translational applications where defined components are desirable.
组织类器官是一项很有前景的技术,可能会加速社会和美国国立卫生研究院对精准医学的要求的发展。在此,我们描述了一种通过使用化学成分明确的水凝胶材料和化学成分明确的培养基,从人类多能干细胞生成脑类器官(cOrgs)的强大且简单的方法。由于未使用额外的神经诱导成分,cOrgs在10 - 14天内在水凝胶表面出现,并且在静态培养条件下,到第28天时其最大尺寸可达3毫米。组织学上,类器官显示出神经玫瑰花结和神经管样结构以及早期皮质发生的证据。免疫染色和定量逆转录聚合酶链反应证明了代表前脑、中脑和后脑发育的蛋白质和基因表达。生理学研究表明许多细胞对谷氨酸和去极化有反应,这与神经行为一致。本文所述的脑类器官生成方法便于获取该技术,实现可扩展应用,并为需要明确成分的转化应用提供了一条潜在途径。
组织类器官是一项很有前景的技术,有许多潜在应用,如药物筛选和体外疾病模型的开发,特别是对于动物模型不足的人类多基因疾病。这项工作描述了一种通过使用化学成分明确的水凝胶材料和化学成分明确的培养基,从人类诱导多能干细胞生成脑类器官的强大且简单的方法。这种方法凭借其简单性和使用明确的材料,极大地便于获取脑类器官技术,实现可扩展应用,并为需要明确成分的转化应用提供了一条潜在途径。